Physician profile
Marina Shtern
NPI 1467489740
$1,258.28
in general payments reported to CMS, 2019-2025
18 companies · $230 in 2025
The $230 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $16.24 · 2021: $57.73 · 2022: $230 · 2023: $335 · 2024: $199 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $764.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $364.74 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $200.50 | 2019-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $183.25 | 2019-2025 | Vraylar |
| Glaxosmithkline, LLC. | $120.15 | 2020-2023 | Shingrix, Arexvy, Bexsero |
| Pfizer INC. | $100.30 | 2021-2024 | |
| Amgen INC. | $50.18 | 2019-2024 | Evenity, Prolia |
| Alexion Pharmaceuticals, INC. | $39.95 | 2022 | |
| Sanofi Pasteur INC. | $27.99 | 2025 | |
| Dexcom, INC. | $23.13 | 2023 | Dexcom G6 Transmitter |
| Abbott Laboratories | $22.48 | 2021 | |
| Linus Health, INC. | $19.39 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.15 | 2022 | |
| Bausch Health US, LLC | $18.54 | 2025 | Wellbutrin |
| Astrazeneca Pharmaceuticals LP | $15.17 | 2025 | Airsupra |
| Exact Sciences Corporation | $14.70 | 2025 | The Cologuard Plus Collection Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $14.16 | 2022 | |
| Astellas Pharma US INC | $12.97 | 2019 | |
| Merck Sharp & Dohme LLC | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marina Shtern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.